Semicarbazide-sensitive amine oxidase activity exerts insulin-like effects on glucose metabolism and insulin-signaling pathways in adipose cells

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1647, Issue 1-2, 2003, Pages 3-9

  Zorzano, Antonio ^a   Abella, Anna ^a   Marti, Luc ^a   Carpéné, Christian ^b   Palacín, Manuel ^a   Testar, Xavier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CHU RANGUEIL   (France)

Author keywords

Adipocyte; Glucose transport; GLUT4; Phosphatidylinositol 3 kinase; SSAO; VAP 1

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); BENZYLAMINE; GLUCOSE; GLUCOSE TRANSPORTER; HYDROGEN PEROXIDE; INSULIN; INSULIN RECEPTOR KINASE; INSULIN RECEPTOR SUBSTRATE 1; ISOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; STREPTOZOCIN; TYRAMINE; TYROSINE; VANADIC ACID; BENZYLAMINE DERIVATIVE; INSULIN RECEPTOR SUBSTRATE 1 PROTEIN; INSULIN RECEPTOR SUBSTRATE-1 PROTEIN; IRS3 PROTEIN, RAT; IRS3L PROTEIN, HUMAN; PHOSPHOPROTEIN; SEMICARBAZIDE DERIVATIVE;

ADIPOCYTE; ADIPOSE TISSUE CELL; ANIMAL CELL; CELL SURFACE; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HYPERGLYCEMIA; IN VIVO STUDY; INSULIN LIKE ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; ANIMAL; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REVIEW;

ANIMALIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOCYTES; AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; BENZYLAMINES; GLUCOSE; HUMANS; HYPERGLYCEMIA; INSULIN; PHOSPHOPROTEINS; PHOSPHORYLATION; RATS; SEMICARBAZIDES; SIGNAL TRANSDUCTION; VANADATES;

EID: 1242341261     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-9639(03)00039-6     Document Type: Conference Paper

References (54)

1. Lewinsohn R. Amine oxidase in human blood vessels and non-vascular smooth muscle. J. Pharm. Pharmacol. 33:1981;569-575.
2. Lyles G.A., Singh I.J. Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta. J. Pharm. Pharmacol. 37:1985;637-643.
3. Yu P.H., Zuo D.H. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes. 42:1993;594-603.
4. Barrand M.A., Callingham B.A. Monoamine oxidase activities in brown adipose tissue of the rat: some properties and subcellular distribution. Biochem. Pharmacol. 31:1982;2177-2184.
5. Lyles G.A., Bertie K.H. Properties of a semicarbazide-sensitive amine oxidase in rat articular cartilage. Pharmacol. Toxicol. 60:1987;33.
6. Norqvist A., Oreland L. Localization of a semicarbazide-sensitive serotonin-oxidizing enzyme from porcine dental pulp. Biog. Amines. 6:1989;65-74.
7. Fernández de Arriba A., Lizcano J.M., Balsa D., Unzeta M. Contribution of different amine oxidases to the metabolism of dopamine in bovine retina. Biochem. Pharmacol. 42:1991;2355-2361.
8. Lizcano J.M., Fernández de Arriba A., Lyles G.A., Unzeta M. Several aspects on the amine oxidation by semicarbazide-sensitive amine oxidase (SSAO) from bovine lung. J. Neural Transm. 41:1994;415-420.
9. Lizcano J.M., Fernández de Arriba A., Tipton K.F., Unzeta M. Inhibition of bovine lung semicarbazide-sensitive amine oxidase (SSAO) by some hydrazine derivatives. Biochem. Pharmacol. 52:1996;187-195.
10. Zhang X., McIntire W.S. Cloning and sequencing of a copper-containing, topa quinone-containing monoamine oxidase from human placenta. Gene. 179:1996;279-286.
11. Imamura Y., Kubota R., Wang Y., Asakawa S., Kudoh J., Mashima Y., Oguchi Y., Shimizu N. Human retina-specific amine oxidase (RAO): cDNA cloning, tissue expression, and chromosomal mapping. Genomics. 40:1997;277-283.
12. Imamura Y., Noda S., Mashima Y., Kudoh J., Oguchi Y., Shimizu N. Human retina-specific amine oxidase: genomic structure of the gene (AOC2), alternatively spliced variant, and mRNA expression in retina. Genomics. 51:1998;293-298.
13. Mu D., Medzihradsky K.F., Adams G.W., Mayer P., Hines W.M., Burlingame A.L., Smith A.J., Cai D., Klinman J.P. Primary structures for a mammalian cellular and serum copper amine oxidase. J. Biol. Chem. 269:1994;9926-9932.
14. Hogdall E.V.S., Houen G., Borre M., Bundgaard J.R., Larsson L.I., Vuust J. Structure and tissue-specific expression of genes encoding bovine copper amine oxidases. Eur. J. Biochem. 251:1998;320-328.
15. Barrand M.A., Callingham B.A. Solubilization and some properties of a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat. Biochem. J. 222:1984;467-475.
16. Lizcano J.M., Tipton K.F., Unzeta M. Purification and characterization of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) from bovine lung. Biochem. J. 331:1998;69-78.
17. Bono P., Salmi M., Smith D.J., Jalkanen S. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity. J. Immunol. 160:1998;5563-5571.
18. Smith D.J., Salmi M., Bono P., Hellman J., Leu T., Jalkanen S. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J. Exp. Med. 188:1998;17-27.
19. Salmi M., Jalkanen S. A 90-kilodalton endothelial cell molecule mediating lymphocyte binding in humans. Science. 257:1992;1407-1409.
20. Jaakkola K., Nikula T., Holopainen R., Vahasilta T., Matikainen M.T., Laukkanen M.L., Huupponen R., Halkola L., Nieminen L., Hiltunen J., Parviainen S., Clark M.R., Knuuti J., Savunen T., Kaapa P., Voipio-Pulkki L.M., Jalkanen S. In vivo detection of vascular adhesion protein-1 in experimental inflammation. Am. J. Pathol. 157:2000;463-471.
21. Raimondi L., Pirisino R., Ignesti G., Capecchi S., Banchelli G., Buffoni F. Semicarbazide-sensitive amine oxidase activity (SSAO) of rat epididymal white adipose tissue. Biochem. Pharmacol. 41:1991;467-470.
22. Morris N.J., Ducret A., Aebersold R., Ross S.A., Keller S.R., Lienhard G.E. Membrane amine oxidase cloning and identification as a major protein in the adipocyte plasma membrane. J. Biol. Chem. 272:1997;9388-9392.
23. Moldes M., Fève B., Pairault J. Molecular cloning of a major mRNA species in murine 3T3 adipocyte lineage differentiation-dependent expression, regulation, and identification as semicarbazide-sensitive amine oxidase. J. Biol. Chem. 274:1999;9515-9523.
24. Raimondi L., Pirisino R., Banchelli G., Ignesti G., Conforti L., Buffoni F. Cultured preadipocytes produce a semicarbazide-sensitive amine oxidase (SSAO) activity. J. Neural Transm. 32:1990;331-336.
25. Enrique-Tarancón G., Marti L., Morin N., Lizcano J.M., Unzeta M., Sevilla L., Camps M., Palacín M., Testar X., Carpéné C., Zorzano A. Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells. J. Biol. Chem. 273:1998;8025-8032.
26. Fischer Y., Thomas J., Sevilla L., Munoz P., Becker C., Holman G., Kozka I.J., Palacin M., Testar X., Kammermeier H., Zorzano A. Insulin-induced recruitment of glucose transporter 4 (GLUT4) and GLUT1 in isolated rat cardiac myocytes. Evidence of the existence of different intracellular GLUT4 vesicle populations. J. Biol. Chem. 272:1997;7085-7092.
27. Sevilla L., Tomas E., Munoz P., Gumà A., Fischer Y., Thomas J., Ruiz-Montasell B., Testar X., Palacín M., Blasi J., Zorzano A. Characterization of two distinct intracellular GLUT4 membrane populations in muscle fiber. Differential protein composition and sensitivity to insulin. Endocrinology. 138:1997;3006-3015.
28. Livingstone C., James D.E., Rice J.E., Hanpeter D., Gould G.W. Compartment ablation analysis of the insulin-responsive glucose transporter (GLUT4) in 3T3-L1 adipocytes. Biochem. J. 15:1996;487-495.
29. Marti L., Morin N., Enrique-Tarancón G., Prévot D., Lafontan M., Testar X., Zorzano A., Carpéné C. Tyramine and vanadate synergistically stimulate glucose transport in rat adipocytes by amine oxidase-dependent generation of hydrogen peroxide. J. Pharmacol. Exp. Ther. 285:1998;342-349.
30. Enrique-Tarancón G., Castan I., Morin N., Marti L., Abella A., Camps M., Casamitjana R., Palacin M., Testar X., Degerman E., Carpene C., Zorzano A. Biochem. J. 350:2000;171-180.
31. Lyles G.A. Substrate-specificity of mammalian tissue-bound semicarbazide-sensitive amine oxidase. Prog. Brain Res. 106:1995;293-303.
32. Lizcano J.M., Balsa D., Tipton K.F., Unzeta M. The oxidation of dopamine by the semicarbazide-sensitive amine oxidase (SSAO) from rat vas deferens. Biochem. Pharmacol. 41:1991;1107-1110.
33. Raimondi L., Confroti L., Ignesti G., Pirisino R., Buffoni F. Histamine lipolytic activity and semicarbazide-sensitive amine oxidase (SSAO) of rat white adipose tissue (WAT). Biochem. Pharmacol. 46:1993;1369-1376.
34. Fontana E., Boucher J., Marti L., Lizcano J.M., Testar X., Zorzano A., Carpene C. Amine oxidase substrates mimic several of the insulin effects on adipocyte differentiation in 3T3 F442A cells. Biochem. J. 356:2001;769-777.
35. Morin N., Lizcano J.M., Fontana E., Marti L., Smih F., Rouet P., Prevot D., Zorzano A., Unzeta M., Carpene C. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes. J. Pharmacol. Exp. Ther. 297:2001;563-572.
36. Lavan B.E., Lane W.S., Lienhard G.E. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J. Biol. Chem. 272:1997;11439-11443.
37. Sciacchitano S., Taylor S.I. Cloning, tissue expression, and chromosomal localization of the mouse IRS-3 gene. Endocrinology. 138:1997;4931-4940.
38. Smith-Hall J., Pons S., Patti M.E., Burks D.J., Yenush L., Sun X.J., Kahn C.R., White M.F. The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. Biochemistry. 36:1997;8304-8310.
39. Kaburagi Y., Satoh S., Tamemoto H., Yamamoto-Honda R., Tobe K., Veki K., Ymauchi T., Kono-Sugita E., Sekihara H., Aizawa S., Cushman S.W., Akanuma Y., Yazaki Y., Kadowaki T.J. Role of insulin receptor substrate-1 and pp60 in the regulation of insulin-induced glucose transport and GLUT4 translocation in primary adipocytes. J. Biol. Chem. 272:1997;25839-25844.
40. Ogihara T., Shin B.C., Anai M., Katagiri H., Inukai K., Funaki M., Fukushima Y., Ishihara H., Takata K., Kikushi M., Yazaki Y., Asano T. Insulin receptor substrate (IRS)-2 is dephosphorylated more rapidly than IRS-1 via its association with phosphatidylinositol 3-kinase in skeletal muscle cells. J. Biol. Chem. 272:1997;12868-12873.
41. Fantus I.G., Kadota S., Deragon G., Foster B., Posner B.I. Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry. 28:1989;8864-8871.
42. Posner B.I., Faure R., Burgess J.W., Bevan A.P., Lachance D., Zhang-Sun G., Fantus I.G., Ng J.B., Hall D.A., Soo Lum B., Shaver A. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J. Biol. Chem. 269:1994;4596-4604.
43. Lönnroth P., Eriksson J.W., Posner B.I., Smith U. Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes. Diabetologia. 36:1993;113-116.
44. Shisheva A., Shechter Y. Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect. Endocrinology. 133:1993;1562-1568.
45. Green A. The insulin-like effect of sodium vanadate on adipocyte glucose transport is mediated at a post-insulin-receptor level. Biochem. J. 238:1986;663-669.
46. Mooney R.A., Bordwell K.L., Luhowskyi S., Casnellie J.E. The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin-like effect on tyrosine phosphorylation. Endocrinology. 124:1989;422-429.
47. Heffetz D., Rutter W.J., Zick Y. The insulinomimetic agents H2O2 and vanadate stimulate tyrosine phosphorylation of potential target proteins for the insulin receptor kinase in intact cells. Biochem. J. 288:1992;631-635.
48. Castan I., Wijkander J., Manganiello V., Degerman E. Mechanisms of inhibition of lipolysis by insulin, vanadate and peroxovanadate in rat adipocytes. Biochem. J. 339:1999;281-289.
49. Marti L., Abella A., Carpéné C., Palacín M., Testar X., Zorzano A. Combined treatment with benzylamine and low dosages of vanadate enhances glucose tolerance and reduces hyperglycemia in streptozotocin-induced diabetic rats. Diabetes. 50:2001;2061-2068.
50. Meyerovitch J., Farfel Z., Sack J., Shechter Y. Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. Characterization and mode of action. J. Biol. Chem. 262:1987;6658-6662.
51. Yale J.F., Lachance D., Bevan A.P., Vigeant C., Shaver A., Posner B.I. Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats. Diabetes. 44:1995;1274-1279.
52. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259:1993;87-91.
53. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
54. Steppan C.M., Bailey S.T., Bhat S., Brown E.J., Banerjee R.R., Wright C.M., Patel H.R., Ahima R.S., Lazar M.A. The hormone resistin links obesity to diabetes. Nature. 409:2001;307-312.